Chronic Somatic Comorbidity and Excess Mortality Due to Natural Causes in Persons with Schizophrenia or Bipolar Affective Disorder by Laursen, Thomas Munk et al.
Chronic Somatic Comorbidity and Excess Mortality Due
to Natural Causes in Persons with Schizophrenia or
Bipolar Affective Disorder
Thomas Munk Laursen*, Trine Munk-Olsen, Christiane Gasse
National Centre for Register-Based Research, University of Aarhus, Aarhus, Denmark
Abstract
Background: Suicide and death by accidents in persons with schizophrenia and bipolar disorder are common, but excess
mortality from natural death accounts for even more years of life lost. The impact of somatic comorbidity, however, often is
not duly considered in analyses and explanations of excess mortality in patients with psychotic disorders.
Objective/Methods: This study investigates and evaluates the impact of 19 severe chronic diseases on excess mortality due
to diseases and medical conditions (natural death) in individuals with psychotic disorders compared with the general
population using a population-based cohort study in Denmark. Incidence/mortality rate ratios of admission/mortality were
calculated using survival analysis.
Results: Cohort members with psychotic disorders had higher incidence rates of hospital contacts for almost all of the 19
disorders than the general population. The mortality rate ratio (MRR) of natural death was 7.10 (95% CI 6.45, 7.81) for
schizophrenic men, decreasing to 4.64 (95% CI 4.21, 5.10) after adjustment for the somatic disorders. The same pattern
existed in women and in both genders with bipolar disorder. Highest MRRs were observed for psychotic patients without
hospital admissions with the investigated somatic disorders.
Conclusion: Chronic somatic diseases accounted for half of the excess mortality in patients with schizophrenia or bipolar
disorder. Chronic disorders investigated in this paper seem to be under-treated or under-detected among such patients.
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Introduction
Premature death in persons with schizophrenia or bipolar
disorder is well documented, both in descriptions dating back in
history [1] and in recent studies [2–6]. Excess mortality from
diseases and medical conditions (death from natural causes)
accounts for even more years of life lost in these patients than do
suicide and death by accidents [7]. Side-effects of pharmacological
treatment [8], unhealthy diet [9], and high levels of cigarette
smoking [10,11], as well as inadequate medical treatment or
provision of health care [12,13] have been proposed as probable
reasons for the excess mortality from natural causes among
psychotic patients. In particular, unfavourable life style factors as
well as antipsychotic treatment are associated with a range of
somatic disorders, such as diabetes, chronic obstructive pulmonary
disease, and cardiovascular disease, which may constitute the
immediate cause of premature death from natural causes. However,
the impact of somatic comorbidity is often not duly considered in
analyses and explanations of the excess mortality [14].
To contribute to the discussion about the causes of excess
mortality among patients with schizophrenia and bipolar disorder,
we investigated the incidence rates of 19 severe somatic chronic
diseases among persons with psychotic disorders (schizophrenia or
bipolar disorder), and compared these rates (incidence rate ratios)
with those of persons with no record of psychiatric hospital
admission or outpatient contact. Furthermore, we evaluated the
impact of these conditions on the estimates of the excess mortality
(mortality rate ratios) from natural causes.
Methods
Data source and study population
We conducted a population-based cohort study using Danish
register data. The study population comprised all persons born in
Denmark from 1 January 1955 to 1 June 1992 (thus at least 15
years old in 2007) and residing in Denmark at some point during
the period 1995 to 2006. They were identified from The Danish
Civil Registration System [15]. The Civil Registration System was
established in 1968, at which time all persons living in Denmark
were registered and assigned a 10-digit personal identification
number enabling data-linkage. The register records information
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of death and migration out of Denmark).
Data on psychiatric hospitalizations of the entire Danish
population were drawn from the Danish Central Psychiatric Case
Register [16], which is computerized since 1969, and were linked
with the study population using the personal identification number.
Patients with schizophrenia (ICD8: 295 (exclusive 295.79), ICD10:
F20) and bipolar disorder (ICD8: 296.39, 296.19, ICD10: F30, F31)
and with any of the remaining psychiatric diagnoses registered at
psychiatric contact were indentified. Persons were categorized as
having schizophrenia/bipolar disorder or any other psychiatric
diagnosis from the date of their first contact (i.e. out- or inpatient
contact) to a psychiatric hospital with such a diagnosis. Thus,
individuals with a psychiatric contact before 1995, e.g. due to
schizophrenia, would be in the group of persons with schizophrenia
throughout the follow-up period. All Danish citizens have access to
public health care free of charge. Severe mental disorders are only
treated in public hospitals. This ensures almost total coverage of
contacts with psychiatric disorder in the registers.
We applied the Charlson Comorbidity Index [17,18] for
assessing severe chronic somatic diseases. The Index includes 19
severe, chronic diseases to which a weight from one to six to each
disorder isassigned accordingto the severityofthedisease(Table 1).
The score of the Index is the sum of all weights. The Index was
originally constructed to measure the impact of comorbidity on
mortality ina hospitalsetting among breastcancer patients [17] and
it has later been adapted to fit with ICD-10 diagnoses [18].
Data on hospital contacts with the chronic somatic diseases
included in the Charlson Comorbidity Index (Table 1) of the
entire Danish population were drawn from the Danish National
Hospital Register [19] and linked to the study population by the
personal registration number. The Danish National Hospital
Register was established in 1977 and contains information on all
Danish somatic inpatient hospital contacts.
The Charlson Comorbidity Index score was calculated by adding
the individual weights of the particular diseases. The score was
calculated in a time-dependent manner where inpatient contacts
from 1977 onwards were used. From 1995 onwards, outpatient
contacts were also included. Underlying causes of natural death
were identified from the Causes of Death Register [20]. Psychiatric
and somatic diseases were diagnosed and causes of death were
determined using the ICD8 [21] classification system until 31
December 1993, and the ICD10 [22] classification from 1 January
1994. The ICD 9 classification was not used in Denmark.
Statistical analyses
Outcomes of interest were the 19 chronic somatic diseases and
death from natural causes. The follow-up began on 1 January
1995 or on the cohort member’s 15th birthday, whichever came
last. The follow-up ended on 1 July 2007, the day of death, the day
of first admission with a chronic somatic disease (when this was the
outcome), or the day of emigration, whichever came first.
In the calculations of IRRs of the 19 diseases of the Charlson
Index, all persons admitted with the respective disorder from 1977
to 1994 were censored, while persons admitted with one of the
disorders during follow-up were censored on the same day. This
means that we only examined incident admissions for the
respective diseases from 1995 on.
We calculated incidence rates and incidence rateratios (IRRs) for
the 19 somatic diseases and calculated mortality rate ratios (MRR)
for natural death, adjusted or stratified by the Charlson Comor-
bidity Index score (in 5 categories: 0, 1, 2, 3, 4+), comparing persons
Table 1. Number of cases and incidence rates per 1000 person-years under risk for four subgroups of the cohort of the 19 chronic
diseases included in the Charlson Comorbidity Index [18].
Chronic somatic disorder Weight Schizophrenia Bipolar disorder
Other psychiatric
diseases
No psychiatric
admissions
N (cases/1000 PY) N (cases/1000 PY) N (cases/1000 PY) N (cases/1000 PY)
Myocardial infarction 1 74 (0.58) 23 (0.57) 799 (0.63) 6156 (0.25)
Congestive heart failure 1 91 (0.72) 28 (0.69) 493 (0.39) 3065(0.13)
Peripheral vascular disease 1 66 (0.52) 18 (0.45) 950 (0.75) 7443 (0.31)
Cerebrovascular disease 1 167 (1.32) 77 (1.93) 2202 (1.74) 14501 (0.60)
Dementia 1 19 (0.15) 14 (0.35) 228 (0.18) 436 (0.02)
Chronic pulmonary disease 1 481 (3.95) 126 (3.24) 4560 (3.76) 38653 (1.63)
Connective tissue disease 1 73 (0.58) 21 (0.52) 1570 (1.25) 18154 (0.75)
Ulcer disease 1 232 (1.85) 62 (1.55) 2565 (2.05) 13458 (0.56)
Mild liver disease 1 318 (2.54) 82 (2.05) 3330 (2.67) 6647 (0.27)
Diabetes I and II 2 372 (2.98) 74 (1.86) 1711 (1.36) 12950 (0.54)
Hemiplegia 2 26 (0.20) 15 (0.37) 340 (0.27) 2054 (0.08)
Moderate to severe renal disease 2 108 (0.85) 44 (1.10) 794 (0.63) 6085 (0.25)
Diabetes with end organ damage 2 135 (1.07) 23 (0.57) 900 (0.71) 6258 (0.26)
Any tumor 2 214 (1.70) 85 (2.13) 2024 (1.60) 26048 (1.08)
Leukemia 2 10 (0.08) 2 (0.05) 63 (0.05) 885 (0.04)
Lymphoma 2 18 (0.14) 5 (0.12) 182 (0.14) 2195 (0.09)
Moderate to severe liver disease 3 57 (0.45) 18 (0.45) 961 (0.76) 1582 (0.07)
Metastatic solid tumor 3 40 (0.31) 10 (0.25) 442 (0.35) 4798 (0.20)
AIDS 6 33 (0.26) 3 (0.07) 245 (0.19) 901 (0.04)
doi:10.1371/journal.pone.0024597.t001
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psychiatric hospital contacts. Poisson regression with the GEN-
MOD procedure in SAS version 9.2 (SAS Institute Inc, Cary, NC)
was used in the calculation of both IRR and MRR. This method
approximates a Cox regression [23,24].
All IRRs and MRRs were adjusted for or stratified by gender,
calendar time, and age (adjustment for age was made in 5-year
groups). IRRs and MRRs were calculated by log-likelihood
estimation, and Wald’s 95% confidence intervals were used.
The Charlson Comorbidity Index score was examined in the two
oldest5-year cohorts of thestudypopulation; those born in1955–59
andthoseborn in1960–64.Wecalculated95%confidenceintervals
(CIs) on the average Charlson score assuming a normal distribution.
Results
In total, the study population comprised 2,450,812 persons
between 15 and 52 years old at risk for admission with one of the 19
investigated somatic diseases and at risk for natural death. A total of
16,079 cohortees had been in contact with a psychiatric hospital
with schizophrenia and 6,215 with bipolar affective disorder.
Incidence rates and rate ratios of somatic diseases
During the follow-up period from 1995 to 2007, the incidence
rates (new cases per 1000 person years) of the individual 19
chronic somatic diseases were higher among persons with a
psychiatric admission than among persons without psychiatric
hospital admissions (Table 1). The IRRs of hospital contacts of all
19 somatic chronic disorders are displayed in Figures 1 and 2. The
rates of all somatic disorders were higher (resulting in IRRs.1)
among cohort members with schizophrenia or bipolar disorder
than among individuals without psychiatric contacts, except for
connective tissue disease in both disorders (IRR 0.80 (95% CI:
0.63, 1.00) and 0.58 (95% CI: 0.38, 0.89), respectively) and
metastatic solid tumor in bipolar disorder (IRR 0.73 (95% CI:
0.39, 1.36)). Dementia and mild/severe liver disease had the
highest IRR in both disorders: 5.84 (95% CI: 3.69, 9.25); 6.94
(95% CI: 6.20, 7.77), respectively in individuals with schizophrenia
and 11.52 (95% CI: 6.76, 19.65); 5.59 (95% CI: 4.50, 6.96),
respectively in individuals with bipolar disorder (Figures 1 and 2).
Mortality rate ratios of natural death
The MRRs from natural causes were examined in two models
with and without adjustment/stratification for the Charlson
Comorbidity Index score in order to investigate the impact of
the somatic diseases on the excess mortality. We found an MRR of
7.10 for men and 6.06 for women with schizophrenia without
comorbidity adjustment. The MRRs were almost halved in the
adjusted model, to 4.64 in men and 3.03 in women. The same
pattern was present in bipolar disorder where the MRR dropped
from 5.61 to 3.73 in men and from 3.71 to 2.44 in women, Table 2.
Table 3 displays MRRs stratified by Charlson Comorbidity
Index score categories. Among cohort members with a score
equaling zero, indicating no recorded (treated) chronic somatic
disorders, schizophrenic patients had an MRR of 12.71 compared
Figure 1. Incidence rate ratios of 19 somatic chronic diseases among patients with schizophrenia. Follow-up 1995–2007. Solid vertical
line crossing at 1.0 is the reference including all persons never admitted to psychiatric hospital.
doi:10.1371/journal.pone.0024597.g001
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Among cohort members with a score equaling one, the MRR was
4.98, declining to 2.59, 1.92, and 1.45, among cohort members
with an index of 2, 3 and 4 or more, respectively. The same
pattern was present among bipolar patients, Table 3.
Somatic comorbidity score
We calculated the average Charlson Comorbidity Index score
as of 1 July 2007 in the two oldest 5-year cohorts of the study
population, i.e., those born 1955–59 and 1960–64, Table 4. In
both sub-cohorts, cohort members with schizophrenia and bipolar
disorder had an average score approximately twice that of the
cohortees with no contact to a psychiatric hospital. Male cohortees
with schizophrenia and bipolar disorder had a lower score than
males with other psychiatric contacts.
Discussion
Key findings
Cohort members with schizophrenia and bipolar disorder had
higher incidence rates of hospital contacts with almost all of the
investigated 19 chronic somatic disorders and had Charlson
Comorbidity Index scores twice as high as persons without a
record of psychiatric admission or outpatient contact. Chronic
Figure 2. Incidence rate ratios of the 19 chronic somatic diseases among patients with bipolar disorder. Follow-up 1995–2007. Solid
vertical line crossing at 1.0 is the reference including all persons never admitted to psychiatric hospital.
doi:10.1371/journal.pone.0024597.g002
Table 2. Mortality rate ratio of death by natural causes in patients with previous hospital admissions/contact due to schizophrenia
or bipolar disorder.
Schizo-phrenia Bipolar disorder Never in contact*
N MRR N MRR N MRR
Men Not adjusted for Charlson I. 451 7.10 (6.45, 7.81) 91 5.61 (4.56, 6.90) 7377 1 ref
Adjusted for Charlson I. 451 4.64 (4.21, 5.10) 91 3.73 (3.03, 4.59) 7377 1 ref
Women Not adjusted for Charlson I. 163 6.06 (5.19, 7.09) 59 3.70 (2.87, 4.80) 5170 1 ref
Adjusted for Charlson I. 163 3.03 (2.60, 3.55) 59 2.44 (1.89, 3.15) 5170 1 ref
*: Comparison with cohortees who have never been in contact with a psychiatric hospital as reference (1 ref=1 reference category). Follow-up 1995–2007.
doi:10.1371/journal.pone.0024597.t002
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excess mortality due to natural causes in cohort members with
schizophrenia and bipolar disorder. Stratification by the Charlson
Comorbidity Index scores revealed that the MRRs among
cohortees with schizophrenia and bipolar disorder were up to
13-fold increased in the strata with a Charlson Comorbidity Index
scores equaling zero compared with cohortees with no contact to a
psychiatric hospital, while the excess mortality decreased with
increasing somatic comorbidity.
Severe chronic somatic comorbidity as evaluated by the
Charlson Comorbidity Index Score
The impact of somatic comorbidity is often not duly considered
in the analysis and explanation of excess mortality among
psychiatric patients [14]. In this paper, we addressed this issue
by investigating 19 chronic somatic diseases and applying the
Charlson Comorbidity Index.
Almost all somatic chronic disorders investigated in this study
were more frequent in psychotic patients than in the general
population. The only somatic disorder with a lower admission rate
in psychotic patients was connective tissue diseases, mainly
rheumatoid arthritis (with symptoms of musculoskeletal pain).
This low admission rate was also noted in a previous Danish study,
which concluded that reporting and detection of musculoskeletal
pain in patients with schizophrenia was at a lower level compared
with the general population [25]. Another Danish study found that
schizophrenic patients had higher admission rates of acute, painful
somatic disorders than non-schizophrenic patients, while they had
lower rates of more chronic, less acute somatic disorders [26].
In our study excess mortality decreased by almost 50% after
adjustment for somatic comorbidity indicating that approximately
half of the excess mortality in men and women with schizophrenia
and bipolar disease is rooted in diseases included in the Charlson
Comorbidity Index. Note that if all of the excess mortality in
psychoticpatients had beenattributable to theexcesslevel of somatic
illnesses included in the Charlson Index, we would expect the MRR
ofnatural death to attenuate to one afterIndex adjustment.This was
not the case. One explanation could be that psychotic patients more
frequently harbor somatic disorders not included in the Charlson
Comorbidity Index than does the general population, e.g. acute
infections [4]. However, infections account for only 0.83% of the
causes of death registered in the general Danish population, thus
may only explain a smaller proportion of the remaining excess risk
[27]. Other disorders not included in the index which are associated
with excess mortality are epilepsy [28], or drug and alcohol abuse
[29]. Substance abuse, for example, has been registered in 32% of
patients with schizophrenia treated with antipsychotics in Denmark
[30]. Although we did not directly adjust for alcohol and substance
abuse and moreover smoking in this study, we adjusted for clinical
conditions related to these risk factors such as COPD, liver diseases
and dementia, which may serve as proxy measures for these factors.
In our opinion, the most plausible explanation that somatic
comorbidity adjustment only halved the excess mortality is an
under-detection of the chronic somatic diseases among psychotic
patients. As shown in both Danish [13] and other studies [31],
psychotic patients appear to be under-diagnosed with somatic
disorders compared with the general population. This notion is
also supported by our finding that the MRR of natural mortality
was almost 13-fold increased among schizophrenic patients and
almost 9-fold in bipolar patients with an index equaling 0
compared with persons who had never been in contact with
psychiatric hospitals. Among all cohortees with a Charlson
Comorbidity Index score equaling zero, many schizophrenic or
bipolar patients may have undetected somatic diseases, which
implies that they are compared within the same strata with more
healthy cohortees without somatic disorders explaining the very
high MRRs observed in the present study. The high MRRs could
not be entirely explained by schizophrenic or bipolar patients
having higher rates of somatic diseases not included in the
Charlson Index as this would have resulted in excess mortality
being more equally distributed among the different strata of the
Charlson Comorbidity Index score.
Table 3. Mortality rate ratio of death by natural causes in patients with previous hospital admissions/contact due to schizophrenia
or bipolar disorder.
Schizophrenia Bipolar disorder Never in contact*
N MRR N MRR N MRR
Charlson index=0 310 12.71(11.31, 14.28) 64 8.68 (6.78, 11.12) 3616 1 ref
Charlson index=1 96 4.98 (4.05, 6.12) 28 4.23 (2.91, 6.16) 1524 1 ref
Charlson index=2 71 2.59 (2.05, 3.28) 22 2.28 (1.50, 3.47) 2557 1 ref
Charlson index=3 30 1.92 (1.33, 2.76) 6 1.18 (0.53, 2.64) 761 1 ref
Charlson index=4+ 107 1.45 (1.20, 1.76) 30 1.37 (0.96, 1.97) 4089 1 ref
*: Comparison with cohortees who have never been in contact with a psychiatric hospital as reference (1 ref=1 reference category). Follow-up 1995–2007.
Stratified by Charlson index score.
doi:10.1371/journal.pone.0024597.t003
Table 4. Average Charlson Index scores among men and
women by birth cohort*.
1955–1959
(age 48–52)
1960–1964
(age 43–47)
Men Schizophrenia 0.61 (0.55–0.67) 0.46 (0.41–0.52)
Bipolar disorder 0.60 (0.50–0.69) 0.33 (0.25–0.40)
Other psych. adm. 0.77 (0.75–0.80) 0.54 (0.52–0.57)
No psych. adm. 0.30 (0.30–0.31) 0.21 (0.21–0.22)
Women Schizophrenia 0.64 (0.57–0.72) 0.47 (0.41–0.54)
Bipolar disorder 0.55 (0.48–0.62) 0.36 (0.29–0.42)
Other psych. adm. 0.64 (0.62–0.64) 0.47 (0.45–0.49)
No psych. adm. 0.32 (0.31–0.32) 0.22 (0.22–0.22)
*: Score was calculated per 1 July 2007. Schizophrenia, bipolar disorder and
other psychiatric disorders were measured as ‘‘lifetime’’ exposure (95% CI).
doi:10.1371/journal.pone.0024597.t004
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Our findings corroborate findings from previous studies from
Australia and Canada reporting higher levels of somatic
admissions in individuals with schizophrenia than in the general
population [32,33]. In a Danish study, schizophrenic patients had
higher admission rates of acute, painful somatic disorders than
non-schizophrenic patients, while they had lower rates of more
chronic, less acute somatic disorders [26]. Furthermore, a higher
prevalence of chronic medical conditions among patients with
psychotic disorders has been shown in the U.S. [34,35]. Moreover,
the results presented here suggest the presence of under-detection
or under-treatment of somatic disorders in this group. We
interpret the lower than expected rates of hospital contacts as
evidence of lack of sufficient somatic treatment, which could shift
the MMR of natural death towards the high observed levels in our
analysis. On the basis of our data analysis, we cannot determine
reasons for the suggested under-treatment. One possible explana-
tion is that patients were not sufficiently examined for which
reason the somatic disorder was not discovered. Another
explanation could be that the somatic disorder was found, but
the patient was not referred to relevant treatment. It could also be
that psychotic patients are more likely to refuse treatment than the
general population.
Register based studies, pros and cons
The diagnostic information in the Psychiatric Central Register
for schizophrenia and bipolar disorder is not as accurate as
information obtained in more structured research settings.
However, a range of studies have shown strong agreement
between the psychiatric clinical diagnoses in the registers and
research criteria diagnoses [36–38].
In Denmark close to 100% of all diagnoses of schizophrenia and
bipolar disorder are registered in the Psychiatric Central Register
because the GPs in virtual 100% of the cases refer patients with
symptoms of schizophrenia or bipolar disorder to an in or out
patients contact to a psychiatric hospital. Therefore, we include all
persons with all levels of severity of the disorders.
In Denmark a major downsizing of psychiatric inpatient
hospitalizations has occurred in the 1980’s and 1990’s where
outpatient and community-based mental health services have been
developed. From the late 1980’s to 2007 the number of psychiatric
beds have been halved [39]. To take this development into
account we have included outpatient contacts from 1995. As we
have no information of outpatient contacts before 1995 a slight
under-representation of less severe cases of schizophrenia and
bipolar disorder would occur in the start of the follow-up.
However, patients in outpatient treatment tend to have many
contacts, and the number of incorrectly assigned person-years
would be limited.
Persons with severe mental disorder tend to live in the larger
cities [40], with e.g. more pollution, which could have a potential
effect on the excess mortality. However, the geographical variation
in e.g. pollution and particular healthcare provision is rather small
in Denmark; thus, we think that the potential effect of geographic
variation must have a limited effect.
We have only included younger persons under the age of 52 in
this study. This should be kept in mind in comparisons with other
studies. We made this restriction because the Danish registries do
not contain complete medical information on persons born before
1955. Moreover, excess mortality in persons with severe mental
disorder is larger among younger persons [4], and thus particularly
relevant from a clinical point of view with regard to prevention.
Conclusion
In conclusion, mortality from natural causes is high in patients
with schizophrenia or bipolar disorder compared with the general
population, and we suggest that this excess mortality may partly be
rooted in higher rates of somatic disorders and partly in under-
detection or under-treatment of the chronic disorders.
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